The Cytoskeleton Differentially Localizes the Early Growth Response Gene-1 Protein in Cancer and Benign Cells of the Prostate

Molecular Cancer Research

Volumn 2, Issue 2, 2004, Pages 115-128

  Mora, Gloria R ^a   Olivier, Kenneth R ^a   Cheville, John C ^a   Mitchell Jr , Richard F ^a   Lingle, Wilma L ^a   Tindall, Donald J ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; MITOGENIC AGENT;

ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER MORTALITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROTUBULE; NUCLEAR LOCALIZATION SIGNAL; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN LOCALIZATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOCARCINOMA; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CYTOSKELETON; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULES; NOCODAZOLE; PACLITAXEL; PROSTATE; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 1342344076     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science, 1987;238:797-9.
2. Sukhatme VP, Cao XM, Chang LC, et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell, 1988;53:37-43.
3. Christy BA, Lau LF, Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc Natl Acad Sci USA, 1988;85:7857-61.
4. DeFranco C, Damon DH, Endoh M, Wagner JA. Nerve growth factor induces transcription of NGFIA through complex regulatory elements that are also sensitive to serum and phorbol 12-myristate 13-acetate. Mol Endocrinol, 1993;7:365-79.
5. Fang MA, Noguchi GM, McDougall S. Epidermal growth factor induces Egr-1 messenger RNA and protein in mouse osteoblastic cells. Calcif Tissue Int, 1995;57:450-5.
6. Ahmed MM, Sells SF, Venkatasubbarao K, et al. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. J Biol Chem, 1997;272:33056-61.
7. Huang RP, Fan Y, deBelle I, Ni Z, Matheny W, Adamson ED. Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ, 1998;5:96-106.
8. Huang RP, Darland T, Okamura D, Mercola D, Adamson ED. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene, 1994;9:1367-77.
9. Huang RP, Liu C, Fan Y, Mercola D, Adamson ED. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res, 1995;55:5054-62.
10. Wu MY, Chen MH, Liang YR, Meng GZ, Yang HX, Zhuang CX. Experimental and clinicopathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma. World J Gastroenterol, 2001;7:490-5.
11. Levin WJ, Press MF, Gaynor RB, et al. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene, 1995;11:1261-9.
12. Huang RP, Fan Y, de Belle I, et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer, 1997;72:102-9.
13. Calogero A, Arcella A, De Gregorio G, et al. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res, 2001;7:2788-96.
14. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther, 1998;5:3-28.
15. Thigpen AE, Cala KM, Guileyardo JM, Molberg KH, McConnell JD, Russell DW. Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma. J Urol, 1996;155:975-81.
16. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG, Tindall DJ. Expression of early growth response genes in human prostate cancer. Cancer Res, 1998;58:2461-8.
17. Abdulkadir SA, Qu Z, Garabedian E, et al. Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med, 2001;7:101-7.
18. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim, 1995;31:14-24.
19. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis, 1997;18:1215-23.
20. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 2. Tumorigenic cell lines. Prostate, 1997;30:58-64.
21. Vallee RB. Purification of brain microtubules and microtubule-associated protein 1 using taxol. Methods Enzymol, 1986;134:104-15.
22. Solomon F. Direct identification of microtubule-associated proteins by selective extraction of cultured cells. Methods Enzymol, 1986;134:139-47.
23. Sentein P. Nocodazole, an antitubulin substance, whose action is different from that of colchicine. Effects on segmentation mitoses. I. Light microscopy. Arch Biol (Liege), 1979;90:459-79.
24. Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV, Fojo T. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol, 2000;2:709-17.
25. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA, 1980;77:1561-5.
26. Carson JH, Worboys K, Ainger K, Barbarese E. Translocation of myelin basic protein mRNA in oligodendrocytes requires microtubules and kinesin. Cell Motil Cytoskeleton, 1997;38:318-28.
27. Kim SJ, Park K, Rudkin BB, Dey BR, Spom MB, Roberts AB. Nerve growth factor induces transcription of transforming growth factor-β1 through a specific promoter element in PC12 cells. J Biol Chem, 1994;269:3739-44.
28. Biesiada E, Razandi M, Levin ER. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J Biol Chem, 1996;271:18576-81.
29. Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MA, Milbrandt J. EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem, 2000;275:38524-31.
30. Yan YX, Nakagawa H, Lee MH, Rustgi AK. Transforming growth factor-α enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter. J Biol Chem, 1997;272:33181-90.
31. 1 transition of the cell cycle. Mol Cell Biol, 1994;14:5242-8.
32. Bonkhoff H, Stein U, Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate, 1994;24:114-8.
33. Wikstrom P, Damber J, Bergh A. Role of transforming growth factor-β1 in prostate cancer. Microsc Res Technol, 2001;52:411-9.
34. Royuela M, De Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Paniagua R. Transforming growth factor β1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma. Growth Factors, 1998;16:101-10.
35. Ahmed MM, Chendil D, Lele S, et al. Early growth response-1 gene: potential radiation response gene marker in prostate cancer. Am J Clin Oncol, 2001;24:500-5.
36. Abdulkadir SA, Carbone JM, Naughton CK, Humphrey PA, Catalona WJ, Milbrandt J. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol, 2001;32:935-9.
37. Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC, Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol, 1996;16:3545-53.
38. Day ML, Zhao X, Wu S, Swanson PE, Humphrey PA. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells. Cell Growth & Differ, 1994;5:135-41.
39. Schamhorst V, Menke AL, Attema J, et al. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene, 2000;19:791-800.
40. Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA. Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate, 1987;11:327-37.
41. Alexandrova N, Niklinski J, Bliskovsky V, et al. The N-terminal domain of c-Myc associates with α-tubulin and microtubules in vivo and in vitro. Mol Cell Biol, 1995;15:5188-95.
42. el Khyari S, Bourgarel V, Barra Y, Braguer D, Briand C. Pretreatment by tubulin agents decreases C-MYC induction in human colon carcinoma cell line HT29-D4. Biochem Biophys Res Commun, 1997;231:751-4.
43. Ranganathan S, Salazar H, Benetatos CA, Hudes GR. Immunohistochemical analysis of β-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy. Prostate, 1997;30:263-8.
44. Helfand BT, Mikami A, Vallee RB, Goldman RD. A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organization. J Cell Biol, 2002;157:795-806.
45. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res, 1983;11:1475-89.
46. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976;72:248-54.